Skip to main content
. 2018 Oct 16;9(81):35226–35240. doi: 10.18632/oncotarget.26215

Figure 6. Ribociclib improves response depth when combined with letrozole in a hormone-dependent breast cancer model.

Figure 6

Combination of ribociclib with letrozole in the HBCx-34 tumor model. Treatment was administered for 56 days (black dotted line). Error bars show the standard error of the mean.